BR-4628

a mineralocorticoid receptor antagonist

Also Known As:

ethyl 5-acetyl-2,6-dimethyl-4-(2-methyl-4-oxo-4H-chromen-8-yl)-1,4-dihydropyridine-3-carboxylate

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Han, Yingjie: 1 article (01/2015)
2.	Kolkhof, Peter: 1 article (01/2015)
3.	Ma, Frank Y: 1 article (01/2015)
4.	Nikolic-Paterson, David J: 1 article (01/2015)
5.	Tesch, Greg H: 1 article (01/2015)

1.	Albuminuria 01/01/2015 - "In comparison, mice which received BR-4628 displayed similar albuminuria, but had improved renal function, reduced severity of glomerular tuft lesions and a 50% reduction in crescents. "
2.	Glomerulonephritis 01/01/2015 - "Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628."

1.	Mineralocorticoid Receptor Antagonists